Discovery weighs up expanding access to Ozempic-style drugs
A new survey shows that 14% of wealthier South Africans are buying weight-loss drugs. Discovery is weighing up the economics…
Suggestions
Discovery, fit and flexing, defies market rout
Discovery has pumped money into growing its bank and investment business, while grabbing market share in life insurance and medical aid…
Discovery, humbled by poor crisis management, does a U-turn
Discovery’s ham-fisted efforts to recoup money paid in error to some members is a lesson in how not to manage a crisis…
Protecting small business from Eskom’s chokehold
A new plan from Discovery will see the company wheeling electricity to small businesses…
Discovery, six years and R15bn later, makes bank
Discovery poured R15bn into launching its bank. With SA’s fragile economy squeezing its medical business, it’s a good thing the bank is in the…
Most Read
Virtual AGMs: dialling down shareholder democracy
The virtual-only AGM had its heyday during Covid. But it’s…
PPC’s comeback starts to cement itself
PPC’s CEO argues there’s still value in squeezing the business…
Renewables: plugging the localisation gap
Billions are flowing into South Africa’s green economy. But are…
Cash-flush Omnia sails through Iran crisis
The fertiliser and chemicals group is a far cry from…
